Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Clinical ShowCase™: Finding the Optimal Dosage of Neuromuscular Blockade for Your Patients

Release Date: November 9, 2020
Expiration Date: November 9, 2021

Activity Overview

This online activity is designed to provide concise and easy-to-digest education in an engaging and interactive case-based format. The case focuses on diagnosing inadequate neuromuscular blockade reversal in a patient who has been treated with general anesthesia. The engaging format of this program includes interactive clinical decision points with explanations at the end of the activity and an evidence-based review supporting the teaching points covered in the case.

Acknowledgement of Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward anesthesiologists, surgeons, and nurse anesthetists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the reversal of neuromuscular blockade are also invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Evaluate optimal strategies for determining whether neuromuscular blockade is residual.
  • Assess patient characteristics that impact strategies for reversing residual neuromuscular blockade.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Jonathan S. Jahr, MD, DABA, FASA
Jonathan S. Jahr, MD, DABA, FASA
Professor Emeritus of Anesthesiology & Perioperative Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosures: Speaker's Bureau: Merck, Salix.

Sophia A.S. Dunworth, MD
Sophia A.S. Dunworth, MD
Department of Anesthesiology
Stanford Health Care
Stanford, CA

Disclosures: Sophia A.S. Dunworth, MD, has no relevant financial relationships with commercial interests.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By